PF-DcpSi

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePF-DcpSi
Drug Alias NamePF-DcpSi
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionScavenger mRNA-decapping enzyme DcpS inhibitors
TargetsScavenger mRNA-decapping enzyme DcpS
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy, Spinal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A